INMB Inmune Bio, Inc.
Nasdaq · SEC CIK 1711754 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 87 since 2021-07-09, latest 2026-09-23 06:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Juda Scott | Dir | — | — |
| Lowdell Mark William | CSO | — | — |
| Moss David J | CEO, Dir | — | — |
Transactions 44
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-07 07:01 | 2026-07-02 | INMB | Juda Scott | Dir | M - OptEx | $1.40 | +14.8K | 86.4K | +21% | +$20.7K |
| D | 2026-07-07 07:01 | 2026-07-02 | INMB | Lowdell Mark William | CSO | M - OptEx | $1.40 | +7,211 | 1.52M | +0.5% | +$10.1K |
| D | 2026-07-07 07:00 | 2026-07-02 | INMB | Moss David J | CEO, Dir | M - OptEx | $1.40 | +9,014 | 1.29M | +0.7% | +$12.6K |
| 2024-09-30 | 2024-09-30 | INMB | Moss David J | CFO, 10% | P - Purchase | $5.29 | +10.0K | 1.29M | +0.8% | +$52.9K | |
| D | 2024-09-16 | 2024-09-12 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | P - Purchase | $6.38 | +15.4K | 1.55M | +1.0% | +$98.1K |
| D | 2024-09-16 | 2024-09-12 | INMB | Moss David J | CFO, 10% | P - Purchase | $6.38 | +7,690 | 1.28M | +0.6% | +$49.1K |
| I | 2024-06-26 | 2024-06-25 | INMB | Juda Scott | Dir | P - Purchase | $7.27 | +5,000 | 71.6K | +8% | +$36.4K |
| DA | 2024-04-24 | 2024-04-19 | INMB | Lowdell Mark William | CSO, 10% | P - Purchase | $8.32 | +14.4K | 1.51M | +1.0% | +$120.0K |
| DA | 2024-04-24 | 2024-04-19 | INMB | Moss David J | CFO, Treas, Sec, 10% | P - Purchase | $8.32 | +18.0K | 1.27M | +1% | +$150.0K |
| DA | 2024-04-24 | 2024-04-19 | INMB | Juda Scott | Dir | P - Purchase | $8.32 | +29.6K | 66.6K | +80% | +$246.3K |
| DA | 2024-04-24 | 2024-04-19 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | P - Purchase | $8.32 | +18.0K | 1.54M | +1% | +$150.0K |
| D | 2024-04-23 | 2024-04-19 | INMB | Juda Scott | Dir | A - Grant | $8.32 | +29.6K | 66.6K | +80% | +$246.3K |
| D | 2024-04-23 | 2024-04-19 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | A - Grant | $8.32 | +18.0K | 1.54M | +1% | +$150.0K |
| D | 2024-04-23 | 2024-04-19 | INMB | Moss David J | CFO, Treas, Sec, 10% | A - Grant | $8.32 | +18.0K | 1.27M | +1% | +$150.0K |
| D | 2024-04-23 | 2024-04-19 | INMB | Lowdell Mark William | CSO, 10% | A - Grant | $8.32 | +14.4K | 1.51M | +1.0% | +$120.0K |
| I | 2023-11-13 | 2023-11-10 | INMB | Juda Scott | Dir | P - Purchase | $6.95 | +7,000 | 37.0K | +23% | +$48.6K |
| I | 2023-07-14 | 2023-07-12 | INMB | Schroeder Timothy j | Dir | S - Sale | $11.01 | -10.0K | 82.2K | -11% | -$110.1K |
| 2023-03-20 | 2023-03-17 | INMB | Moss David J | CFO, Treas, Sec, 10% | P - Purchase | $6.43 | +2,500 | 1.25M | +0.2% | +$16.1K | |
| 2022-05-31 | 2022-05-26 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | P - Purchase | $6.41 | +6,300 | 1.52M | +0.4% | +$40.4K | |
| M | 2022-05-31 | 2022-05-26+ | INMB | Moss David J | CFO, Treas, Sec, 10% | P - Purchase | $6.42 | +10.7K | 1.25M | +0.9% | +$68.6K |
| D | 2022-03-23 | 2022-03-22 | INMB | Lowdell Mark William | CSO, 10% | A - Grant | $8.43 | +23.6K | 1.50M | +2% | +$198.9K |
| D | 2022-03-23 | 2022-03-22 | INMB | Ganjei James Kelly | Dir | A - Grant | $8.43 | +17.8K | 17.8K | New | +$150.0K |
| D | 2022-03-23 | 2022-03-22 | INMB | Moss David J | CFO, Treas, Sec, 10% | A - Grant | $8.43 | +17.8K | 1.24M | +1% | +$150.0K |
| D | 2022-03-23 | 2022-03-22 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | A - Grant | $8.43 | +23.7K | 1.51M | +2% | +$200.0K |
| I | 2021-11-17 | 2021-11-17 | INMB | Juda Scott | Dir | P - Purchase | $13.55 | +2,500 | 30.0K | +9% | +$33.9K |
| 2021-11-04 | 2021-11-03 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | S - Sale | $20.00 | -3,626 | 1.49M | -0.2% | -$72.5K | |
| 2021-11-04 | 2021-11-03 | INMB | Lowdell Mark William | CSO, 10% | S - Sale | $20.00 | -701 | 1.47M | -0.0% | -$14.0K | |
| 2021-11-04 | 2021-11-03 | INMB | Moss David J | CFO, Treas, Sec, 10% | S - Sale | $20.00 | -1,025 | 1.22M | -0.1% | -$20.5K | |
| 2021-10-29 | 2021-10-27 | INMB | Lowdell Mark William | CSO, 10% | S - Sale | $20.00 | -2,357 | 1.47M | -0.2% | -$47.1K | |
| 2021-10-29 | 2021-10-27 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | S - Sale | $20.00 | -6,517 | 1.49M | -0.4% | -$130.3K | |
| 2021-10-29 | 2021-10-27 | INMB | Moss David J | CFO, Treas, Sec, 10% | S - Sale | $20.00 | -2,079 | 1.22M | -0.2% | -$41.6K | |
| M | 2021-10-26 | 2021-10-22+ | INMB | Moss David J | CFO, Treas, Sec, 10% | S - Sale | $20.00 | -1,155 | 1.22M | -0.1% | -$23.1K |
| 2021-10-26 | 2021-10-22 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | S - Sale | $20.00 | -23.6K | 1.50M | -2% | -$472.3K | |
| 2021-10-26 | 2021-10-22 | INMB | Lowdell Mark William | CSO, 10% | S - Sale | $20.00 | -400 | 1.48M | -0.0% | -$8,000 | |
| A | 2021-09-08 | 2021-06-10 | INMB | Xencor Inc | 10% | J - Other | $17.14 | +192.5K | 1.78M | +12% | +$3.30M |
| A | 2021-09-08 | 2021-06-10 | INMB | Xencor Inc | 10% | J - Other | $17.14 | +192.5K | 1.78M | +12% | +$3.30M |
| D | 2021-09-08 | 2021-09-03 | INMB | Xencor Inc | 10% | M - OptEx | $7.80 | +108.0K | 1.89M | +6% | +$842.4K |
| D | 2021-08-27 | 2021-08-25 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | M - OptEx | $3.91 | +30.0K | 1.52M | +2% | +$117.3K |
| D | 2021-07-19 | 2021-07-16 | INMB | Moss David J | CFO, Treas, Sec, 10% | M - OptEx | $3.91 | +25.0K | 1.22M | +2% | +$97.8K |
| I | 2021-07-14 | 2021-07-13 | INMB | Schroeder Timothy j | Dir | S - Sale | $27.63 | -14.5K | 92.2K | -14% | -$400.1K |
| I | 2021-07-12 | 2021-07-09 | INMB | Schroeder Timothy j | Dir | S - Sale | $23.21 | -30.0K | 106.7K | -22% | -$696.3K |
| M | 2021-07-09 | 2021-07-07+ | INMB | Tesi Raymond Joseph | Pres, CEO, Dir | S - Sale | $20.07 | -30.0K | 1.51M | -2% | -$602.1K |
| M | 2021-07-09 | 2021-07-07+ | INMB | Moss David J | CFO, Treas, Sec | S - Sale | $20.06 | -25.0K | 1.20M | -2% | -$501.6K |
| M | 2021-07-09 | 2021-07-07+ | INMB | Lowdell Mark William | CSO | S - Sale | $20.16 | -30.0K | 1.48M | -2% | -$604.7K |
Purchase Sale Sale after option exercise All abbreviations